[ Price : $8.95]
FDA accepts for review a Coherus BioSciences BLA for CHS-1420, a biosimilar to AbbVies Humira (adalimumab).[ Price : $8.95]
Federal Register notice: FDA determines that Arbor Pharmaceuticals Nymalize (nimodipine) oral solution was not withdrawn from sale...[ Price : $8.95]
Federal Register notice: FDA announces a 4/15 meeting of its Cellular, Tissue and Gene Therapies Advisory Committee to discuss a C...[ Price : $8.95]
CBER director Peter Marks says FDA is finding ways to encourage the timely evolution of cancer therapies while still having enough...[ Price : $8.95]
The Justice Department says sports supplement company owner Brian Parks was sentenced to time in prison and forfeited $350,000 for...[ Price : $8.95]
Attorney Matthew Decker outlines five key provisions of an FDA action plan on the regulation of artificial intelligence and machin...[ Price : $8.95]
Bluebird Bio temporarily suspends studies of LentiGlobin gene therapy for sickle cell disease due to a reported unexpected serious...[ Price : $8.95]
FDA cybersecurity advisor Jessica Wilkerson urges security controls wherever they can be built into hardware and software.